Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03108066
Title PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Peloton Therapeutics, Inc.
Indications

clear cell renal cell carcinoma

Therapies

PT2385

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST